Tag: Silk Road
Boston Scientific completes acquisition of Silk Road Medical
Boston Scientific announced the close of its acquisition of Silk Road Medical, the company behind transcarotid artery revascularization (TCAR).
"The integration of the TCAR platform into our portfolio...
New survey shows transcarotid artery revascularization patients report faster recovery than...
This advertorial is sponsored by Silk Road Medical.
For Scott Berman, MD, patient responses when confronted with an explanation of the extent of their asymptomatic...
TCAR: First patient enrolled in ROADSTER 3 post-approval study
Silk Road Medical has announced enrollment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicenter, single-arm...
Silk Road to evaluate TCAR in standard surgical risk patients with...
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularization (TCAR) system in the treatment of standard surgical risk patients...
Expanded Medicare coverage for TCAR in standard surgical risk patients...
Silk Road Medical today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery's Patient Safety...
FDA approves expanded indications for TCAR’s Enroute stent
The Food and Drug Administration (FDA) approved expanded indications for the Enroute stent system—part of the transcarotid artery revascularization (TCAR) procedure—to include patients at...